Quest Laboratories (NSE:QUESTLAB) Marketable Securities: ₹131.1 Mil (As of Mar. 2026)


NSE:QUESTLAB Quest Laboratories Ltd NSE:QUESTLAB
44 GF Score
Price ₹98.05
! 8 Warning Signs
View Full Analysis

What is Quest Laboratories Marketable Securities?

Quest Laboratories NSE:QUESTLAB -1.56% 44 Marketable Securities is ₹131.1 Mil as of Mar. 2026. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 44/100. The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Quest Laboratories's Marketable Securities for the quarter that ended in Mar. 2026 was ₹131.1 Mil.

Quest Laboratories's annual Marketable Securities increased from Mar. 2024 (₹67.6 Mil) to Mar. 2025 (₹492.3 Mil) but then declined from Mar. 2025 (₹492.3 Mil) to Mar. 2026 (₹131.1 Mil).

Quest Laboratories  (NSE:QUESTLAB) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Quest Laboratories Marketable Securities Related Terms

Quest Laboratories Marketable Securities Historical Data

* Premium members only.

The historical data trend for Quest Laboratories's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Laboratories Marketable Securities Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial 0.00 25.33 67.56 492.25 131.08

Quest Laboratories Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Mar25 Mar26
Marketable Securities Get a 7-Day Free Trial 0.00 0.00 67.56 492.25 131.08
NSE:QUESTLAB
44GF Score
Quest Laboratories Ltd NSE:QUESTLAB
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Laboratories Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹131.1 Mil mean?
Quest Laboratories (NSE:QUESTLAB) has a Marketable Securities of ₹131.1 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Quest Laboratories and its competitors.
Is Quest Laboratories' Marketable Securities too high?
Quest Laboratories' current Marketable Securities is ₹131.1 Mil. Overall, Quest Laboratories has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' Marketable Securities compare to LLY and JNJ?
Quest Laboratories' Marketable Securities of ₹131.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Quest Laboratories and its competitors. Quest Laboratories's current Marketable Securities is ₹131.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current Marketable Securities of ₹131.1 Mil. The current Marketable Securities is ₹131.1 Mil. Quest Laboratories' overall GF Score™ is 44/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current Marketable Securities is ₹131.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest Laboratories Business Description

Address Sector III, Plot No. 45, Pithampur Industrial Area, Opposite Kissan Pipe Unit 4, District Dhar, Pithampur, Dhar, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
44GF Score

Get the complete analysis for NSE:QUESTLAB

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹98.05
Price